Journal of Health and Insurance Law – Sickness (JDSAM) – Number 2015/2 – No. 10 – Biosimilar medicines: what are the challenges in 2015?

by

2015-02-28 23:00:00
Page 8 to 22: François Bocquet and Pascal Paubel – Biosimilar medicines: which legal framework for which economic model? | Page 23 to 33: Alice Bousselet and Sophie Dufay – Analysis of regulations for biosimilar drugs in emerging countries and study of the characteristics of these markets | Page 34 to 35: Éric Baseilhac – Developing biosimilar drugs: mirages and reality.
1710923418
#Journal #Health #Insurance #Law #Sickness #JDSAM #Number #Biosimilar #medicines #challenges

Photo of author

Alexandra Hartman Editor-in-Chief

Editor-in-Chief Prize-winning journalist with over 20 years of international news experience. Alexandra leads the editorial team, ensuring every story meets the highest standards of accuracy and journalistic integrity.

Sony Xperia 1 VI and 5 VI: real images of covers leak before launch

US court temporarily stops a controversial migration law in Texas – USA

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.